High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas

Pancreas

Volumn 25, Issue 2, 2002, Pages 122-129

  Niedergethmann, Marco ^a   Hildenbrand, Ralf ^a   Wostbrock, Birgit ^a   Hartel, Mark ^a   Sturm, Jörg W ^a   Richter, Axel ^a   Post, Stefan ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Ductal pancreatic adenocarcinoma; Microvessel density (MVD); Prognosis; Recurrence; Vascular endothelial growth factor (VEGF)

Indexed keywords

MESSENGER RNA; VASCULOTROPIN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ANTIGENS, CD34; BLOOD VESSELS; CARCINOMA, PANCREATIC DUCTAL; ENDOTHELIAL GROWTH FACTORS; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOKINES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PANCREATIC NEOPLASMS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RNA, MESSENGER; SURVIVAL ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036311535     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006676-200208000-00002     Document Type: Article

References (40)

1. Prognostic factors in ductal pancreatic cancer
2. Survival after pancreaticoduodenectomy: 118 Consecutive resections without an operative mortality
3. The role of gemcitabine alone and in combination in the treatment of pancreatic cancer
4. Surgical options for pancreatic cancer
5. Long-term survival after curative resection for pancreatic ductal adenocarcinoma: Clinico-pathologic analysis of 5-year survivors
6. Prognostic factors in the operative treatment of ductal pancreatic carcinoma
7. Invasion and metastasis in pancreatic cancer
8. Molecular mechanisms of tumor metastasis and angiogenesis
9. Enhanced expression of VEGF in human pancreatic cancer correlates with local disease progression
10. Induction of angiogenesis during the transition from hyperplasia to neoplasia
11. Clinical applications of research on angiogenesis
12. Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma
13. Implication of VEGF in the development and metastasis of human cancers
14. Angiogenesis and cathepsin expression are prognostic factors in pancreatic cancer after curative resection
15. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
16. Analysis of survival data under the proportional hazards model
17. AIDS-associated Kaposi's sarcoma cells in culture express vascular endothelial growth factor
18. A simplified in situ hybridization protocol using nonradioactive labeled probes to detect abundant and rare mRNAs on tissue sections
19. Nonparametric estimation from incomplete observations
20. Evaluation of survival data and two new rank order statistics arising in its consideration
21. Tumor angiogenesis: Therapeutic implications
22. Overexpression of vascular permeability/vascular endothelial growth factor and its receptors in psoriasis
23. Prognostic significance of angiogenesis in human pancreatic cancer
24. Growth factors, cytokines and soluble forms of receptor molecules in cancer patients
25. The implications of angiogenesis for the biology and therapy of cancer metastases
26. Correlation between TGF-betal and p21 (WAF1/CIPI) expression and prognosis in resectable invasive ductal carcinoma of the pancreas
27. Angiogenesis, angiogenic growth factors, and cell adhesion molecules are upregulated in chronic pancreatic diseases: Angiogenesis in chronic pancreatitis and in pancreatic cancer
28. Tumor angiogenesis and tumor cell proliferation as prognostic indicators in gastric carcinoma
29. The relationship between microvessel density, the expression of VEGF, and the extension of nasopharyngeal carcinoma
30. Overexpression of VEGF is responsible for hematogenous recurrence of early stage gastric cancer
31. Intratumoral neovascularization and growth pattern, in early gastric carcinoma
32. The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma: A quantitative histologic study
33. Expression and secretion of type beta transforming growth factor by activated human macrophages
34. Urokinase and macrophages in tumor angiogenesis
35. Standards for pancreatic resection in the 1990s
36. Molecular prognostic markers in pancreatic cancer
37. Pancreaticoduodenectomy for pancreatic adenocarcinoma: Postoperative adjuvant chemoradiation improves survival: A prospective, single-institution experience
38. Current status of and future prospects for the medical management of adenocarcinoma of the exocrine pancreas
39. Improved survival and local control after intraoperative radiation therapy and postoperative radiotherapy: A multivariate analysis of 46 patients undergoing surgery for pancreatic head cancer
40. Gemcitabine following radiotherapy with concurrent 5-fluorouracil for nonmetastatic adenocarcinoma of the pancreas